15 mg E4/3 mg DRSP
Sponsors
Estetra
Conditions
ContraceptionHemostasis ParameterLiver MetabolismPrevention of Pregnancy
Phase 1
Effect of Food on the Bioavailability of 15 mg Estetrol/3 mg Drospirenone Tablets in Healthy Female Volunteers
CompletedNCT02852681
Start: 2015-08-31End: 2016-04-30Updated: 2016-08-02
E4/DRSP Single and Multiple Dose PK and Early QT Study
CompletedNCT02874248
Start: 2016-05-31End: 2016-11-21Updated: 2017-04-21
E4/DRSP Endocrine Function, Metabolic Control and Hemostasis Study
CompletedNCT02957630
Start: 2016-09-30End: 2017-10-09Updated: 2018-02-05
Phase 2
Phase 3
E4 FREEDOM (Female Response Concerning Efficacy and Safety of Estetrol/Drospirenone as Oral Contraceptive in a Multicentric Study) - United States/Canada Study
CompletedNCT02817841
Start: 2016-08-30End: 2018-11-16Updated: 2020-02-10
E4 FREEDOM (Female Response Concerning Efficacy and Safety of Estetrol/Drospirenone as Oral Contraceptive in a Multicentric Study) - EU/Russia Study
CompletedNCT02817828
Start: 2016-06-30End: 2018-04-26Updated: 2019-10-04